MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients.

Oncotarget · 2017 · PMC5584175 · PMID 28881587

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

A marginal significance value related to refractory disease was also observed, in which 38.1% (08/21) of the tumors presenting MGMT methylation were refractory to standard platinum-based chemotherapy (p=0.067, Table 3 ).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.